279
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Telemedical Diabetic Retinopathy Screening in a Primary Care Setting: Quality of Retinal Photographs and Accuracy of Automated Image Analysis

ORCID Icon, , , , , & ORCID Icon show all
Pages 286-295 | Received 05 Dec 2020, Accepted 27 May 2021, Published online: 20 Jun 2021
 

ABSTRACT

Background

Screening for diabetic eye disease (DED) and general diabetes care is often separate, which leads to delays and low adherence to DED screening recommendations. Thus, we assessed the feasibility, achieved image quality, and possible barriers of telemedical DED screening in a point-of-care general practice setting and the accuracy of an automated algorithm for detection of DED.

Methods

Patients with diabetes were recruited at general practices. Retinal images were acquired using a non-mydriatic camera (CenterVue, Italy) by medical assistants. Images were quality assessed and double graded by two graders. All images were also graded automatically using a commercially available artificial intelligence (AI) algorithm (EyeArt version 2.1.0, Eyenuk Inc.).

Results

A total of 75 patients (147 eyes; mean age 69 years, 96% type 2 diabetes) were included. Most of the patients (51; 68%) preferred DED screening at the general practice, but only twenty-four (32%) were willing to pay for this service. Images of 63 patients (84%) were determined to be evaluable, and DED was diagnosed in 6 patients (8.0%). The algorithm’s positive/negative predictive values (95% confidence interval) were 0.80 (0.28–0.99)/1.00 (0.92–1.00) and 0.75 (0.19–0.99)/0.98 (0.88–1.00) for detection of any DED and referral-warranted DED, respectively.

Overall, the number of referrals was 18 (24%) for manual telemedical assessment and 31 (41%) for the artificial intelligence (AI) algorithm, resulting in a relative increase of referrals by 72% when using AI.

Conclusions

Our study shows that achieved overall image quality in a telemedical GP-based DED screening was sufficient and that it would be accepted by medical assistants and patients in most cases. However, good image quality and integration into existing workflow remain challenging. Based on these findings, a larger-scale implementation study is warranted.

Declaration of interests statement

Else Kröner-Fresenius-Stiftung/German Scholars Organization (EKFS/GSO 16) provided funding to Finger RP, and the BONFOR GEROK Program, Faculty of Medicine, University of Bonn (Grant No. O-137.0028), provided funding to Wintergerst MWM. Eyenuk Inc. provided free automated analyses of digital retinal images for this study. Wintergerst MWM received a travel grant and imaging devices from DigiSight Technologies, was a consultant for and received a grant, travel reimbursements, and imaging devices from Heine Optotechnik, and received honoraria and travel reimbursements from ASKIN & CO GmbH, a grant and travel reimbursements from Berlin-Chemie AG, and imaging devices from D-EYE. Bejan V, Hartmann V, Schnorrenberg M, Bleckwenn M, and Weckbecker K have nothing to disclose. Finger RP was a consultant for Bayer, Novartis, Santen, Opthea, Novelion, Retina Implant, and Oxford Innovation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.

Supplementary material

Supplemental data for this article can be accessed on the publisher’s website.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.